If left unrecognized or inappropriately managed, adenomatous-like nodular hyperplasia develops, which is associated with reduced expression of vitamin D and calcium-sensing receptors, and thus being less responsive to vitamin D analogues or calcimimetics [16]. The gene discussed is CASR; the disease is hyperplasia.